Page last updated: 2024-10-27

foscarnet and Hepatitis D

foscarnet has been researched along with Hepatitis D in 2 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Hepatitis D: INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research Excerpts

ExcerptRelevanceReference
"Foscarnet has been shown to inhibit the proliferation of human T and B lymphocytes in vitro."1.28Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response? ( Hansson, BG; Nordenfelt, E; Riesbeck, K; Weiland, O, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hansson, BG2
Riesbeck, K1
Nordenfelt, E2
Weiland, O2
Hedin, G1
Ljunggren, K1
Strömberg, A1
Oberg, B1

Other Studies

2 other studies available for foscarnet and Hepatitis D

ArticleYear
Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?
    Progress in clinical and biological research, 1991, Volume: 364

    Topics: Antiviral Agents; B-Lymphocytes; Cell Line; Cells, Cultured; DNA; Foscarnet; Hepatitis B; Hepatitis

1991
Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet.
    Progress in clinical and biological research, 1987, Volume: 234

    Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Female; Foscarnet; Hepatitis B; Hepatitis D; Hum

1987